Systemic antifungal drugs.
D000666:Amphotericin B / Q000008:administration & dosage / Q000009:adverse effects / Q000633:toxicity; D000855:Anorexia / Q000139:chemically induced; D000935:Antifungal Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D001228:Aspergillosis / Q000188:drug therapy; D001759:Blastomycosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D003047:Coccidioidomycosis / Q000188:drug therapy; D003453:Cryptococcosis / Q000188:drug therapy; D051544:Cytochrome P-450 CYP3A; D065607:Cytochrome P-450 Enzyme Inhibitors; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D015725:Fluconazole / Q000494:pharmacology; D005437:Flucytosine / Q000633:toxicity; D006177:Gynecomastia / Q000139:chemically induced; D006660:Histoplasmosis / Q000188:drug therapy; D006801:Humans; D017964:Itraconazole / Q000009:adverse effects / Q000097:blood; D007654:Ketoconazole / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced; D008081:Liposomes; D008297:Male; D006899:Mixed Function Oxygenases / Q000037:antagonists & inhibitors; D009091:Mucormycosis / Q000188:drug therapy; D009325:Nausea / Q000139:chemically induced; D010229:Paracoccidioidomycosis / Q000188:drug therapy; D013174:Sporotrichosis / Q000188:drug therapy; D013723:Teratogens
D000935:Antifungal Agents; D065607:Cytochrome P-450 Enzyme Inhibitors; D008081:Liposomes; D013723:Teratogens; D017964:Itraconazole; D000666:Amphotericin B; D015725:Fluconazole; D005437:Flucytosine; D006899:Mixed Function Oxygenases; C104464:CYP3A protein, human; D051544:Cytochrome P-450 CYP3A; D007654:Ketoconazole